- Home
- CPOP vs VERU Comparison
CPOP vs VERU Comparison
Compare CPOP & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPOP | VERU |
|---|---|---|
| Founded | 2007 | 1971 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 39.8M |
| IPO Year | 2021 | 1990 |
Fundamental Metrics
Financial Performance| Metric | CPOP | VERU |
|---|---|---|
| Price | $0.45 | $2.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | 50.0K | ★ 174.8K |
| Earning Date | 11-17-2025 | 12-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $107,632,769.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 127.16 | N/A |
| 52 Week Low | $0.39 | $2.11 |
| 52 Week High | $2.61 | $14.20 |
Technical Indicators
Market Signals| Indicator | CPOP | VERU |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 43.86 |
| Support Level | $0.42 | $2.23 |
| Resistance Level | $0.48 | $2.49 |
| Average True Range (ATR) | 0.03 | 0.18 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 69.31 | 37.74 |
Price Performance
Historical ComparisonAbout CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.